Country Condo’s

India Founded: 1987 • Age: 39 yrs Listed
Pharmaceutical distribution services are provided by Country Condos in India.

About Country Condo’s

Country Condo’s is a publicly listed company based in India founded in 1987. Pharmaceutical distribution services are provided by Country Condos in India. The company has 20 employees. Its Indian entity Country Condo's Limited reported revenue of ₹17.49 Cr. Its focus areas include Pharmaceutical Distributors and Diversified. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.

Company details

Country Condos was established in 1987 in India, where pharmaceutical distribution services are managed. Operations are centered on supplying pharmaceutical products to various clients within the sector. The companys activities are conducted primarily in the Indian market, with a focus on efficient distribution networks. Online presence is maintained through the domain countrycondos.co.in. Sector involvement remains limited to pharmaceuticals, supporting regional healthcare needs.

  • Headquarters India
  • Employees 20
  • Stage Public
  • Sectors
    Healthcare
  • Website countrycondos.co.in
  • Social LinkedIn
  • Legal Name Country Condo's Limited
Key Metrics
  • Market Cap
    ₹48.73 Cr

    COUNCODOS · NSE

  • Revenue
    ₹17.48 Cr

    FY 2025-26 · +4.6% YoY

  • EBITDA
    ₹1.01 Cr

    Margin 5.8%

  • Net Profit
    ₹0.59 Cr

    FY 2025-26 · 0.0% YoY

  • P/E (TTM)
    80.4x

    P/B 1.9x

  • Employee Count
    20

Board of directors of Country Condo's Limited (Country Condo’s)

Country Condo's Limited is the primary company behind Country Condo’s. The board of Country Condo's Limited currently have 10 directors; the longest-serving is Krishnakumar Raju Datla, appointed in 1987. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Krishnakumar Raju Datla
DIN 00115553
Director25 Sep 198739 yrs 1 moCountry Condo's Limited
Rajeev Reddy Yedaguri
DIN 00115430
Director10 Aug 200917 yrs 3 moCountry Condo's Limited
Varun Yedaguri Reddy
DIN 01905757
Director10 Aug 200917 yrs 3 moCountry Condo's Limited
Yedaguri Siddharth Reddy
DIN 00815456
Director10 Aug 200917 yrs 3 moCountry Condo's Limited
Manjula Reddy Yedaguri
DIN 00115485
Director29 May 201412 yrs 5 moCountry Condo's Limited
Subramanya Raju Kalidindi
DIN 00094663
Director28 Jun 20179 yrs 4 moCountry Condo's Limited
Korlepara Srirama Chandra Murthy
DIN 08197054
Director30 Jun 20206 yrs 4 moCountry Condo's Limited
Peethala Krupavaram
DIN 08197063
Director30 Jun 20206 yrs 4 moCountry Condo's Limited
Srinivas Pasham
DIN 10273557
Director05 Aug 20242 yrs 3 moCountry Condo's Limited
Rama Lingeswara Swamy Namburi
DIN 10720140
Director05 Aug 20242 yrs 3 moCountry Condo's Limited

IPO & Listings of Country Condo’s

Country Condo’s is a publicly listed company on the NSE with ticker symbol COUNCODOS in India, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date22 Jan 2009
  • Listed onNSE: COUNCODOS
  • Listed entityCountry Condo's Limited
  • Exchange sectorFinance
  • ISININE695B01025
  • Share price₹6.38 (+0.79% on the day) · 2026-10-14
  • Market capitalisation₹48.3 Cr
  • Price to earnings80.7
  • EPS (diluted, trailing year)₹0.08
  • Volume (last session)25,611

Financials of Country Condo’s

Exchange-reported figures of Country Condo's Limited, the listed company behind Country Condo’s (NSE: COUNCODOS).

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹17.48 Cr
+4.6% YoY
EBITDA
₹1.01 Cr
-12.2% YoY
Profit After Tax
₹0.59 Cr
0.0% YoY
Net Worth
₹25.69 Cr
+2.4% YoY
Total Assets
₹25.69 Cr
+2.1% YoY
Total Debt
Nil

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue17.4816.7125.3221.1021.9312.4417.89
Revenue growth+4.6%-34.0%+20.0%-3.8%+76.3%-30.5%-
EBITDA1.011.151.651.36(0.50)1.121.67
EBITDA margin+5.8%+6.9%+6.5%+6.5%-2.3%+9.0%+9.3%
Profit before tax0.870.831.941.103.000.620.85
Net profit0.590.591.030.82(0.53)0.450.62
Net profit margin+3.4%+3.5%+4.1%+3.9%-2.4%+3.6%+3.5%
EPS (₹)0.080.080.210.100.330.060.08
Balance sheet
Total assets25.6925.1526.4524.5522.1919.8620.15
Net worth25.6925.1024.5022.8922.0819.5619.09
Total debt0.000.051.951.660.110.311.06
Cash & bank0.790.373.724.084.442.974.32
Net working capital25.0924.4425.6323.1720.9015.4815.32
Cash flow
Cash from operations0.49(1.34)(0.92)(1.64)(1.47)(0.66)1.90
Cash from investing(0.03)(0.03)0.41(0.24)3.160.14(0.34)
Cash from financing(0.05)(1.97)0.161.52(0.22)(0.83)(0.13)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.103.684.435.833.542.624.904.99
Revenue growth (YoY)+15.8%+40.5%-9.6%+16.8%-15.7%---
Other income0.000.000.000.010.000.010.040.03
Total expenses3.873.344.295.513.332.434.674.73
EBITDA0.230.340.140.320.210.190.230.26
EBITDA margin+5.6%+9.2%+3.2%+5.5%+5.9%+7.3%+4.7%+5.2%
Depreciation0.030.040.040.040.040.040.040.04
Interest0.000.000.000.000.000.000.020.03
Profit before tax0.200.300.100.290.170.160.210.22
Tax0.050.120.030.090.040.060.060.07

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 16 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.103.684.435.833.542.624.904.99
Revenue growth (YoY)+15.8%+40.5%-9.6%+16.8%-15.7%---
Other income0.000.000.000.010.000.010.040.03
Total expenses3.873.344.295.513.332.434.674.73
EBITDA0.230.340.140.320.210.190.230.26
EBITDA margin+5.6%+9.2%+3.2%+5.5%+5.9%+7.3%+4.7%+5.2%
Depreciation0.030.040.040.040.040.040.040.04
Interest0.000.000.000.000.000.000.020.03
Profit before tax0.200.300.100.290.170.160.210.22
Tax0.050.120.030.090.040.060.060.07
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue17.4816.7125.3221.1021.9312.4417.89
Revenue growth+4.6%-34.0%+20.0%-3.8%+76.3%-30.5%-
Other income0.010.100.830.153.900.160.12
Total expenses16.4715.5623.6719.7422.4311.3216.22
Employee cost0.004.935.004.654.013.262.60
EBITDA1.011.151.651.36(0.50)1.121.67
EBITDA margin+5.8%+6.9%+6.5%+6.5%-2.3%+9.0%+9.3%
Depreciation0.150.160.160.150.170.340.36
Interest0.000.260.380.260.230.320.58
Profit before tax0.870.831.941.103.000.620.85
Tax0.280.240.340.280.450.160.23
Net profit0.590.591.030.82(0.53)0.450.62
Net profit margin+3.4%+3.5%+4.1%+3.9%-2.4%+3.6%+3.5%
EPS (₹)0.080.080.210.100.330.060.08
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital7.767.767.767.767.767.767.76
Reserves & surplus17.9317.3416.7415.1314.3211.8011.33
Shareholders' funds (net worth)25.6925.1024.5022.8922.0819.5619.09
Secured loans0.000.051.951.660.110.180.33
Unsecured loans0.000.000.000.000.000.130.73
Total debt0.000.051.951.660.110.311.06
Total liabilities25.6925.1526.4524.5522.1919.8620.15
Assets
Gross block2.612.582.552.962.727.087.30
Net block0.540.650.781.351.264.595.06
Capital work in progress0.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.00
Inventories42.9433.7626.5125.2622.9819.7217.22
Sundry debtors0.000.000.000.000.000.000.00
Cash & bank balances0.790.373.724.084.442.974.32
Loans & advances0.662.352.612.452.423.543.90
Total current assets44.3936.4832.8431.7929.8426.2325.44
Total current liabilities19.3012.047.218.628.9410.7510.12
Net working capital25.0924.4425.6323.1720.9015.4815.32
Total assets25.6925.1526.4524.5522.1919.8620.15
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash0.373.724.084.442.974.322.89
Net cash from operating activities0.49(1.34)(0.92)(1.64)(1.47)(0.66)1.90
Net cash from investing activities(0.03)(0.03)0.41(0.24)3.160.14(0.34)
Net cash from financing activities(0.05)(1.97)0.161.52(0.22)(0.83)(0.13)
Net change in cash0.42(3.35)(0.36)(0.36)1.47(1.35)1.43
Closing cash0.790.373.724.084.442.974.32
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.6%-34.0%+20.0%-3.8%+76.3%-30.5%-
EBITDA growth-12.2%-30.3%+21.3%+372.0%-144.6%-32.9%-
PBT growth+4.8%-57.2%+76.4%-63.3%+383.9%-27.1%+11.8%
Net income growth0.0%-42.7%+25.6%+254.7%-217.8%-27.4%-
Revenue CAGR (3Y)-6.1%-8.7%+26.7%+5.7%+2.6%-19.5%-13.0%
EBITDA CAGR (3Y)-9.4%-+13.8%-6.6%--8.0%+6.1%
Profitability & leverage
Net income margin+3.4%+3.5%+6.3%+3.9%+11.6%+3.7%+3.5%
Return on capital employed-+4.3%+6.4%+5.8%-2.7%+4.8%+7.2%
Return on net worth-+2.4%+4.4%+3.6%-2.6%+2.4%+3.3%
Debt / equity-0.040.080.040.010.040.06
Long-term debt / equity-0.000.000.000.010.040.06
Interest cover0.0026.2625.5021.49-34.3341.0344.27
Efficiency & per share
Fixed asset turnover-6.519.197.434.481.732.51
Inventory turnover-0.550.980.871.030.671.13
Debtors turnover-0.000.000.000.000.000.00
EPS (₹)0.080.080.210.100.330.060.08
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.003.233.162.952.852.522.46

Similar companies to Country Condo’s

Country Condo’s has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
keimed.com2000Hyderabad, India$16.62M588
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
sandor.co.in1995Hyderabad, India$8.98M161
Provider of medical equipment, devices, and drugs distribution services
Premium access

Detailed similar companies of Country Condos

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Country Condo’s

The website of Country Condo’s (countrycondos.co.in) receives about 8K visits a month.

  • Monthly visits
    8K

    ▲ 732.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Country Condo’S

Premium access

Complete news archive for Country Condos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Country Condo’s

Country Condo’s was founded in 1987.

Country Condo’s is headquartered in India.

Country Condo’s has 20 employees.

The primary company behind Country Condo’s, Country Condo's Limited, reported revenue of ₹17.49 Cr for FY 2026, up 5% year on year.

Country Condos was established in 1987 in India, where pharmaceutical distribution services are managed. Operations are centered on supplying pharmaceutical products to various clients within the sector. The companys activities are conducted primarily in the Indian market, with a focus on efficient distribution networks. Online presence is maintained through the domain countrycondos.co.in. Sector involvement remains limited to pharmaceuticals, supporting regional healthcare needs.

Country Condo’s's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.

Yes, Country Condo’s is publicly traded on NSE under the ticker symbol COUNCODOS.

Country Condo’s operates through Country Condo's Limited.

The legal entities of Country Condo’s currently have 12 directors, including Rajeev Reddy Yedaguri, Manjula Reddy Yedaguri, Krishnakumar Raju Datla and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available